EdiShorts
UPSC Mains 2008GS Paper II (old)Q10(a) · 30 marksSci & TechModel answer

In what way ‘Medical Biotechnology’ and ‘Bioengineering’ are useful for technological development of India ?

DirectiveExplain
Marks30
Word limit250
PaperGS Paper II (old)
What the examiner wants

Define the two fields, then show with Indian institutions, products and programmes how each contributes to India's technological development, and note the constraints.

Common trap: Weak answers give textbook definitions and generic 'cures diseases'. A top answer separates the two fields, gives Indian examples (recombinant vaccines and insulin, Chitra heart valve, Jaipur Foot, stem-cell guidelines, the 2007 biotech strategy) and links them to self-reliance, affordability, exports and jobs.

SyllabusOld-pattern GS Paper II (2006–12): Developments in Science & Technology — biotechnology and its applications

Model answer

30 marks · 250-word limit

Medical biotechnology uses living cells, molecules and genetic engineering to develop diagnostics, vaccines, therapeutics and gene-based medicine. Bioengineering applies engineering principles to biology and medicine, producing implants, devices, prosthetics, imaging systems and engineered tissues. Together they can give India affordable, home-grown health technologies and a knowledge-based industry.

Health technology for India
  • Affordable recombinant vaccines and drugs
  • Rapid diagnostic kits
  • Stem cells and regenerative medicine
  • Genomics and personalised medicine
  • Low-cost implants and devices
  • Prosthetics such as the Jaipur Foot
  • Exports, jobs and bio-clusters
How medical biotechnology and bioengineering help India

Medical biotechnology: contributions

  • Vaccines and biologics: Indian firms made a recombinant hepatitis B vaccine (Shantha Biotechnics, 1997) and recombinant human insulin, cutting prices sharply; India is a major supplier of vaccines to UNICEF and developing countries.
  • Diagnostics: ELISA and PCR-based kits for HIV, hepatitis, malaria and TB allow early, cheap diagnosis in public health programmes.
  • Regenerative medicine: Stem-cell research for heart, eye and blood disorders is governed by the ICMR–DBT Guidelines for Stem Cell Research and Therapy (2007).
  • Genomics: The Indian Genome Variation Consortium maps genetic diversity of Indian populations, a base for pharmacogenomics and personalised medicine.

Bioengineering: contributions

  • Implants and devices: The Sree Chitra Tirunal Institute (Thiruvananthapuram) developed the TTK–Chitra mechanical heart valve and other biomaterials at a fraction of import cost.
  • Prosthetics: The Jaipur Foot is a celebrated low-cost artificial limb used by hundreds of thousands of amputees in India and abroad.
  • Equipment and tissue: Indigenous imaging, dialysis and monitoring equipment, and tissue-engineered skin and cartilage reduce dependence on imports.

Wider technological gains

  • Industry: Biotech parks and clusters in Bangalore, Hyderabad and Pune, and clinical research and contract manufacturing, generate exports and high-skill jobs.
  • Policy support: The Department of Biotechnology (1986) and the National Biotechnology Development Strategy (2007) fund research, human resources and public-private partnerships.
  • Spillovers: Bioinformatics links biotech with India's IT strength; nanotechnology and biosensors open new device markets.

Constraints

  • Gaps: Low R&D spending, weak academia–industry links, a slow multi-agency regulatory system, IPR concerns and ethical issues in clinical trials and stem-cell use.

Medical biotechnology and bioengineering can make India a provider of affordable health technology for itself and the developing world. A single, science-based regulator, higher R&D funding and stronger industry-academia linkages would turn this potential into technological leadership.

Answer length. This model answer runs to about 321 words so that every relevant angle is covered. In the exam, write to the 250-word limit: keep the opening, the strongest one or two points under each heading, the diagram and the conclusion.

Read more — sources

  • OfficialDepartment of Biotechnology, National Biotechnology Development Strategy (2007)
  • OfficialICMR–DBT, Guidelines for Stem Cell Research and Therapy (2007)
  • NCERTBiology (Class XII) — Ch. 11 Biotechnology: Principles and Processes; Ch. 12 Biotechnology and its Applications

More from GS Paper II (old) 2008

Model answer by the EdiShorts editorial team. It is one well-argued treatment of the question, written to the official word limit — not an official UPSC answer key.